Total voting rights: BB Medtech AG: Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution

BB Medtech AG / Total voting rights: Disclosure pursuant to article
26a WpHG

Publication pursuant to §26a WpHG (the German Securities Trading Act)
processed and transmitted by Hugin. The issuer is solely responsible
for the content of this announcement.

----------------------------------------------------------------------
--------------

Pursuant to article 26a WpHG BB MEDTECH AG, Vordergasse 3, 8200
Schaffhausen, Switzerland hereby announces that the new number of
voting rights amounts to 13 050 000. The new number of voting rights
is effective as at
February 6, 2009.

For further information please contact:
Bellevue Asset Management AG, Seestrasse 16, CH-8700 Küsnacht/Zürich
Anja Stubenrauch or Michael Hutter, Tel. +41 44 267 67 00.

Company profile
BB MEDTECH acquires shares in companies in the growth market of
medical technology. BB MEDTECH is listed on the Swiss Stock Exchange
and in Germany. The focus of the shareholdings is on listed companies
that are taking on a market leadership role in their area of
activities and demonstrate sustained turnover and income potential.
For its selection of holdings, BB MEDTECH relies on fundamental
analysis by industry experts. The Board of Directors has many years
of industrial and scientific experience behind it.

--- End of Message ---

BB Medtech AG
Vordergasse 3 Schaffhausen Switzerland

WKN: 898194 ;
ISIN: CH0000428661; Index: TECH All Share, TecDAX, Prime All Share;
Listed: Prime Standard in Frankfurter Wertpapierbörse, Regulierter
Markt in Frankfurter Wertpapierbörse;
Copyright © Hugin AS 2009. All rights reserved.